Effects of supplementation with polyunsaturated fatty acids in patients with heart failure

Internal and Emergency Medicine

Volumn 6, Issue SUPPL. 1, 2011, Pages

  Nodari, Savina ^a   Triggiani, Marco ^a   Manerba, Alessandra ^a   Milesi, Giuseppe ^a   Cas, Livio Dei ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Heart failure; Left ventricular function; Metabolic therapy; n 3 PUFAs; Non ischemic cardiomyopathy

Indexed keywords

UNSATURATED FATTY ACID;

AGED; DIET SUPPLEMENTATION; FEMALE; HEART FAILURE; HUMAN; MALE; METABOLISM; MIDDLE AGED; REVIEW; UNITED STATES;

AGED; DIETARY SUPPLEMENTS; FATTY ACIDS, UNSATURATED; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; UNITED STATES;

EID: 84857071989     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-011-0671-y     Document Type: Article

References (81)

1. McCullough PA, Philbin EF, Spertus JA, Kaatz S et al (2002) Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 39(1):60-69
2. Rosamond W, Flegal K, Furie K, Go A et al (2008) Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117(4):e25-e146
3. O'Connell JB (2000) The economic burden of heart failure. Clin Cardiol 23 (3 Suppl):III6-10
4. Hunt SA, Abraham WT, Chin MH, Feldman AM et al (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112(12):e154-e235
5. Heart Failure Society Of America (2006) HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 12(1):e1-e2
6. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29(19):2388-2442
7. Fang J, Mensah GA, Croft JB, Keenan NL (2008) Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol 52(6):428-434
8. Tang WH, Francis GS (2003) Trends and treatment of heart failure developing after acute myocardial infarction. Am Heart Hosp J 1(3):216-218
9. Wu AH, Parsons L, Every NR, Bates ER (2002) Hospital out-comes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 40(8):1389-1394
10. Butler J, Kalogeropoulos A (2008) Worsening heart failure hospitalization epidemic we do not know how to prevent and we do not know how to treat!. J Am Coll Cardiol 52(6):435-437
11. Gissi Prevenzione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354:447-455
12. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV et al (2003) Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Car-diology. Eur Heart J 24:28-66
13. Kris-Etherton PM, Harris WS, Appel LJ (2002) for the American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106:2747-2757
14. Rogans JA (1987) More on fish oil. N Engl J Med 316:624-628
15. Dei Cas L, Nodari S (2003) Ruolo degli acidi grassi poliinsaturi PUFA n-3 nella prevenzione della morte improvvisa. Excerpta Medica, pp 1-80
16. Weber PC (1986) Fischer 5, von Schacky C, Lorenz R, et al. Dietary omega-3 polyunsaturated fatty acids and eicosanoid formation in man. In: Simopoulos AP, Kifer RR, Martin RE (eds) Health effects of polyunsaturated fatty acids in seafoods. Academic Press, Orlando, FL, pp 49-60
17. Lewis RA, Lee TH, Austen KF (1986) Effects of omega-3 fatty acids on the generation of products of the 5-lipoxygenase pathway. In: Simopoulos AP, Kifer RR, Martin RE (eds) Health effects of polyunsaturated fatty acids in seafoods. Academic Press, Orlando, FL, pp 227-238
18. Braunwald E, Bristow (2000) Congestive heart failure: fifty years of progress. Circulation 102(20 Suppl 4):IV14-23
19. Xu HE, Lambert MH, Montana VG, Parks DJ et al (1999) Molecular recognition of fatty acids by peroxisome proliferatoractivated receptors. Mol Cell 3:397-403
20. Kliewer SA, Sundseth SS, Jones SA, Brown PJ et al (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci U S A 94(9):4318-4323
21. Sack MN, Rader TA, Park S, Bastin J et al (1996) Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 94:2837-2842
22. Pepe S, McLennan PL (2007) (n-3) Long chain PUFA dosedependently increase oxygen utilization efficiency and inhibit arrhythmias after saturated fat feeding in rats. J Nutr 137(11): 2377-2383
23. Pepe S, McLennan PL (2002) Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation 105: 2303-2308
24. Castellani S, Paladini B, Paniccia R, Di Serio C et al (1997) Increased renal formation of thromboxane A2 and prostaglandin F2 alpha in heart failure. Am Heart J 133(1):94-100
25. Aukrust P, Gullestad L, Ueland T, Damas JK et al (2005) Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications. Ann Med 37(2):74-85
26. Valen G, Yan ZQ, Hansson GK (2001) Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38:307-314
27. Wong SC, Fukuchi M, Melnyk P, Rodger I et al (1998) Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. Circulation 98:100-103
28. Matsumori A, Sasayama S (2001) The role of inflammatory mediators in the failing heart: immunomodulation of cytokines in experimental models of heart failure. Heart Fail Rev 6:129-136
29. Mehra MR, Lavie CJ, Ventura HO, Milani RV (2006) Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J Heart Lung Transplant 25(7):834-838
30. Zhao YT, Shao L, Teng LL, Hu B et al (2009) Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure. J Int Med Res 37(6):1831-1841
31. Eschen O, Christensen JH LA, Rovere MT, Romano P et al (2010) Effects of marine n-3 fatty acids on circulating levels of soluble adhesion molecules in patients with chronic heart failure. Cell Mol Biol. 56(1):45-51 Noisy-le-grand
32. Shibata R, Ouchi N, Ito M, Kihara S et al (2004) Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10:1384-1389
33. Shibata R, Ouchi N, Ito M, Kihara S et al (2004) Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10:1384-1389
34. Hopkins TA, Ouchi N, Shibata R, Walsh K (2007) Adiponectin actions in the cardiovascular system. Cardiovasc Res 74:11-18
35. Wang Y, Lam JB, Lam KS, Liu J et al (2006) Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDAMB-231 cells in nude mice. Cancer Res 66:11462-11470
36. Frankel DS, Vasan RS, D'Agostino RB Sr et al (2009) Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J Am Coll Cardiol 53:754-762
37. Duda MK, O'Shea KM, Lei B et al (2007) Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodelling and dysfunction with pressure overload. Cardiovasc Res 76:303-310
38. Duda MK, O'Shea KM, Tintinu A, Xu W et al (2009) Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res 81(2):319-327
39. Mozaffarian D, Gottdiener JS, Siscovick DS (2006) Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics. Am J Cardiol 97(2):216-222
40. Matsumoto T, Nakayama N, Ishida K et al (2009) Eicosapenta-enoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. J Pharmacol Exp Ther 329:324-334
41. Morgan DR, Dixon LJ, Hanratty CG, El-Sherbeeny N et al (2006) Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure. Am J Cardiol 97(4):547-551
42. Omura M, Kobayashi S, Mizukami Y et al (2001) Eicosapenta-enoic acid (EPA) induces Ca(2)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent asorelaxation. FEBS Lett 487:361-366
43. Harris WS, Rambjør GS, Windsor SL, Diederich D (1997) n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr 65(2):459-464
44. Mori TA, Watts GF, Burke V et al (2000) Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 102:1264-1269
45. Mcveigh GE, Brennan GM, Cohn JN et al (1994) Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler Thromb 14:1425-1429
46. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR et al (2002) Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 20 (8): 1493-1499
47. Mozaffarian D, Geelen A, Brouwer IA et al (2005) Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 112:1945-1952
48. Charnock JS, McLennan PL, Abeywardena MY (1992) Dietary modulation of lipid metabolism and mechanical performance of the heart. Mol Cell Biochem 116:19-25
49. McLennan PL, Barnden LR, Bridle TM, Abeywardena MY et al (1992) Dietary fat modulation of left ventricular ejection fraction in the marmoset due to enhanced filling. Cardiovasc Res 26:871-877
50. Vargiu R, Littarru GP, Fraschini M, Perinu A et al (2010) Enhancement of shortening velocity, power, and acto-myosin crossbridge (CB) kinetics following long-term treatment with propionyl-L-carnitine, coenzyme Q10, and omega-3 fatty acids in BIO TO-2 cardiomyopathic Syrian hamsters papillary muscle. Biofactors. 36(3):229-239
51. Vargiu R, Littarru GP, Faa G, Mancinelli R (2008) Positive inotropic effect of coenzyme Q10, omega-3 fatty acids and propionyl-L-carnitine on papillary muscle force-frequency responses of BIO TO-2 cardiomyopathic Syrian hamsters. Biofactors 32(1-4):135-144
52. Berecki G, Den Ruijter HM, Verkerk AO, Schumacher CA et al (2007) Dietary fish oil reduces the incidence of triggered arrhythmias in pig ventricular myocytes. Heart Rhythm 4(11):1452-1460
53. Engelstein ED (2003) Prevention and management of chronic heart failure with electrical therapy. Am J Cardiol 91(9A):62F-73F
54. Kang JX, Leaf A (1996) Evidence that free polyunsaturated fatty acids modify Na? channels by directly binding to the channel proteins. Proc Natl Acad Sci USA 93:3542-3546
55. Leaf A, Kang JX, Xiao YF, Billman GE (2003) Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 107:2646-2652
56. Seidler T, Hasenfuss G, Maier LS (2007) Targeting altered cal-cium physiology in the heart: translational approaches to excitation, contraction, and transcription. Physiology (Bethesda) 22:328-334
57. Mozaffarian D, Geelen A, Brouwer IA et al (2005) Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 112:1945-1952
58. Billman GE, Hallaci H, Leaf A (1994) Prevention of ischemiainduced ventricular fibrillation by omega 3 fatty acids. Proc Natl Acad Sci USA 91:4427-4430
59. Billman GE, Kang JX, Leaf A (1999) Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation 99:2452-2457
60. Bucher HC, Hengstler P, Sdiindler C, Meier G (2002) N-3 polyunsaturated fatty acids in coronary heart disease: a metaanalysis of randomized controlled trials. Am J Med 112:298-308
61. Raitt MH, Connor WE, Morris C et al (2005) Fish oil supple-mentation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 293:2884-2891
62. Leaf A, Albert CM, Josephson M et al (2005) Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 112:2762-2768
63. Brouwer IA, Zock PL, Camm AJ et al (2006) Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 295:2613-2619
64. Burr ML, Fehily AM, Gilbert JF, Rogers S et al (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2(8666):757-761
65. Albert CM, Campos H, Stampfer MJ, Ridker PM et al (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346(15):1113-1118
66. Nodari S, Metra M, Milesi G, Manerba A et al (2009) The Role of n-3 PUFAs in Preventing the Arrhythmic Risk in Patients with Idiopathic Dilated Cardiomyopathy. Cardiovasc Drugs Ther 23:5-15
67. Christensen JH, Gustenhoff P, Korup E et al (1996) Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ 312:677-678
68. Christensen JH, Korup E, Aaroe J et al (1997) Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol 79:1670-1673
69. Mozaffarian D, Rimm EB (2006) Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 296(15):1885-1899
70. Mozaffarian D (2008) Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death. Am J Clin Nutr 87(6):1991S-1996S
71. Mozaffarian D, Bryson CL, Lemaitre RN, Burke GL, Siscovick DS (2005) Fish intake and risk of incident heart failure. J Am Coll Cardiol 45:2015-2021
72. Yamagishi K, Nettleton JA, Folsom AR (2008) Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J 156:965-974
73. Levitan EB, Wolk A, Mittleman M (2009) Fish consumption, marine omega-3 fatty acids and incidence of heart failure: a population-based prospective study of middle-aged and elderly men. Eur Heart J 30:1495-1500
74. GISSI-HF Investigators et al (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372(9645):1223-1230
75. Ghio S, Scelsi L, Latini R, Masson S et al (2010) Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial. Eur J Heart Fail 12(12):1345-1353
76. Nodari S, Triggiani M, Campia U, Manerba A et al (2011) Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol 57(7):870-879
77. Harris WS (2007) Omega-3 fatty acids and cardiovascular disease a case for omega-3 index as a new risk factor. Pharmacol Res 55:217-223
78. USDA Agricultural Research Service. Nutrient Data Laboratory. Available at: http://www.ars.usda.gov/nutrientdata/url/e-link. Accessed January 23, 2008
79. Park Y, Harris WS (2003) Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res 44(3):455-463 Epub 2002 Dec 1
80. Harris WS, Poston WC, Haddock CK (2007) Tissue n-3 and n-6fatty acids and risk for coronary heart disease events. Atherosclerosis. 193(1):1-10
81. Rupp H, Rupp TP, Alter P, Maisch B (2010) Inverse shift in serum polyunsaturated and monounsaturated fatty acids is associated with adverse dilatation of the heart. Heart 96(8):595-598